{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:38:25Z","timestamp":1777354705186,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>The aim of present study is to inverstigate the association between antibody levels after vaccination with 7-valent pneumococcal conjugate vaccine (PCV7) and subsequent serious pneumococcal infections in rheumatoid arthritis (RA) and spondylarthropathy (SpA) patients.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>A cohort of 497 patients (RA\u2009=\u2009248 and SpA\u2009=\u2009249) received a single dose of PCV7. At vaccination, patients were treated with methotrexate (MTX; n\u2009=\u200985), anti-tumour necrosis factor (anti-TNF)\u2009+\u2009MTX (n\u2009=\u2009169), anti-TNF monotherapy (n\u2009=\u2009158) and non-steroidal anti-inflammatory drugs (NSAIDs)\/analgesics (n\u2009=\u200985). Antibody levels of serotypes 6B and 23B were analyzed before and 4 to 6 weeks after vaccination using standard enzyme-linked immunosorbent assay (ELISA). Serious pneumococcal infections (pneumonia\/lower respiratory tract infection, meningitis, sepsis, septic arthritis) occurring within 4.5 years after vaccination were identified in the Sk\u00e5ne Healthcare Register using the International Classification of Diseases, tenth revision (ICD-10) codes. The association between post-vaccination antibody levels and protection against infections and determination of protective cutoff levels was explored using receiver operating characteristic (ROC) curves. Predictors of infection were studied using regression analyses.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Eighteen infections were registered in 15 patients before vaccination and 27 infections in 23 patients after vaccination. Patients with serious infections after vaccination had significantly lower post-vaccination antibody titres for both 6B (<jats:italic>P<\/jats:italic>\u2009=\u20090.04) and 23 F (<jats:italic>P<\/jats:italic>\u2009=\u20090.04). Post-vaccination antibody levels of at least 1.29 mg\/L and 1.01 mg\/L for 6B and 23, respectively, were associated with better protection from serious infections. Higher age, concomitant prednisolone but not MTX or anti-TNF were associated with such infections.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Patients with more robust antibody responses after vaccination with pneumococcal conjugate vaccine were less likely to suffer from serious infections. High age and prednisolone at vaccination were associated with putative serious pneumococcal infections in this cohort.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Trial registration number<\/jats:title>\n                        <jats:p>EudraCT EU 2007-006539-29 and <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02240888\">NCT00828997<\/jats:ext-link>. Registered 23 January 2009.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-015-0636-z","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T09:26:26Z","timestamp":1431595586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients"],"prefix":"10.1186","volume":"17","author":[{"given":"Johanna","family":"Nagel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Geborek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tore","family":"Saxne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Englund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingemar F","family":"Petersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-\u00c5ke","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart","family":"Truedsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meliha C","family":"Kapetanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"636_CR1","unstructured":"World Health Organization. Pneumococcal disease. Available at: http:\/\/www.who.int\/immunization\/topics\/pneumococcal_disease\/en\/."},{"key":"636_CR2","doi-asserted-by":"publisher","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","volume":"8","author":"MA Said","year":"2013","unstructured":"Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One. 2013;8:e60273. doi:10.1371\/journal.pone.0060273.","journal-title":"PLoS One"},{"key":"636_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/inf.1980.12.issue-2.04","volume":"12","author":"E Herva","year":"1980","unstructured":"Herva E, Luotonen J, Timonen M, Sibakov M, Karma P, M\u00e4kel\u00e4 PH. The effect of polyvalent pneumococcal polysaccharide vaccine on nasopharyngeal and nasal carriage of Streptococcus pneumoniae. Scand J Infect Dis. 1980;12:97\u2013100.","journal-title":"Scand J Infect Dis"},{"key":"636_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10096-006-0161-8","volume":"25","author":"A Mykietiuk","year":"2006","unstructured":"Mykietiuk A, Carratal\u00e0 J, Domininguez A, Manzur A, Fern\u00e0ndez-Sab\u00e9 N, Dorca J, et al. Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis. 2006;25:457\u201362.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"636_CR5","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1093\/infdis\/165-Supplement_1-S49","volume":"165","author":"KE Stein","year":"1992","unstructured":"Stein KE. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis. 1992;165:S49\u201352.","journal-title":"J Infect Dis"},{"key":"636_CR6","unstructured":"Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54:893\u20137."},{"key":"636_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM200102083440602","volume":"344","author":"J Eskola","year":"2001","unstructured":"Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403\u20139.","journal-title":"N Engl J Med"},{"key":"636_CR8","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","volume":"297","author":"RJ Singleton","year":"2007","unstructured":"Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297:1784\u201392.","journal-title":"JAMA"},{"key":"636_CR9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1056\/NEJMoa0903029","volume":"362","author":"A Mykietiuk","year":"2010","unstructured":"Mykietiuk A, Carratal\u00e0 J, Domininguez A, Manzur A, Fern\u00e0ndez-Sab\u00e9 N, Dorca J, et al. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med. 2010;362:812\u201322.","journal-title":"N Engl J Med"},{"key":"636_CR10","unstructured":"Bonten M, Bolkenbaas M, Huijts S. Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Abstract no. 0541. Pneumonia 2014; 3:95. Available at https:\/\/pneumonia.org.au\/public\/journals\/22\/PublicFolder\/ABSTRACTBOOKMASTERforwebupdated20-3-14.pdf."},{"key":"636_CR11","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012; 61:816\u20139.","DOI":"10.1111\/ajt.12073"},{"key":"636_CR12","first-page":"822","volume":"63","author":"S Tomczyk","year":"2014","unstructured":"Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"636_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/03009742.2014.984754","volume":"6","author":"J Nagel","year":"2015","unstructured":"Nagel J, Geborek P, Saxne T, J\u00f6nsson G, Englund M, Petersson IF, et al. The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients. Scand J Rheumatol. 2015;6:1\u20139.","journal-title":"Scand J Rheumatol"},{"key":"636_CR14","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1093\/infdis\/136.Supplement.S43","volume":"136","author":"PH M\u00e4kel\u00e4","year":"1977","unstructured":"M\u00e4kel\u00e4 PH, Peltola H, Kayhty H, Jousimies H, Pettay O, Ruoslahti E, et al. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis. 1977;136:S43\u201350.","journal-title":"J Infect Dis"},{"key":"636_CR15","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","volume":"147","author":"H K\u00e4yhty","year":"1983","unstructured":"K\u00e4yhty H, Peltola H, Karanko V, M\u00e4kel\u00e4 PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983;147:1100.","journal-title":"J Infect Dis"},{"key":"636_CR16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","volume":"17","author":"SA Plotkin","year":"2010","unstructured":"Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17:1055\u201365.","journal-title":"Clin Vaccine Immunol"},{"key":"636_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1128\/CVI.00735-14","volume":"22","author":"H Daly","year":"2015","unstructured":"Daly H, Hill T. Use and clinical interpretation of pneumococcal antibody measurements in the evaluation of humoral immune function. Clin Vaccine Immunol. 2015;22:148\u201352.","journal-title":"Clin Vaccine Immunol"},{"key":"636_CR18","first-page":"1","volume":"927","author":"World Health Organization","year":"2005","unstructured":"World Health Organization. Recommendations for the production and control of pneumococcal conjugate vaccines. World Health Organ Tech Rep Ser. 2005;927:1\u201329.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"636_CR19","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","volume":"25","author":"GR Siber","year":"2007","unstructured":"Siber GR, Chang I, Baker S, Fernsten P, O'Brien KL, Santosham M, et al. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine. 2007;25:3816\u201326.","journal-title":"Vaccine"},{"key":"636_CR20","doi-asserted-by":"crossref","unstructured":"Kapetanovic MC, Roseman C, J\u00f6nsson G, Truedsson L, Saxne T, Geborek P. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors. Arthritis Rheum. 2011; 63:3723\u201332.","DOI":"10.1002\/art.30580"},{"key":"636_CR21","unstructured":"World Health Organization. The WHO consensus pneumococcal IgG ELISA. Training manual for enzyme-linked immunosorbent assay for the quantification of Streptococcus pneumonia serotype specific IgG (Pn PS ELISA): a guide to procedures for qualification of materials and analysis of assay performance. URL: http:\/\/www.vaccine.uab.edu\/ELISA%20Protocol.pdf."},{"key":"636_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.ede.0000147512.81966.ba","volume":"16","author":"EF Schisterman","year":"2005","unstructured":"Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology. 2005;16:73\u201381.","journal-title":"Epidemiology"},{"key":"636_CR23","doi-asserted-by":"crossref","unstructured":"Kapetanovic MC, Roseman C, J\u00f6nsson G, Truedsson L. Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs. Clin Rheumatol. 2011; 30:1555\u201361.","DOI":"10.1007\/s10067-011-1856-5"},{"key":"636_CR24","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/ar4127","volume":"15","author":"MC Kapetanovic","year":"2013","unstructured":"Kapetanovic MC, Saxne T, Truedsson L, Geborek P. Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs. Arthritis Res Ther. 2013;15:R1.","journal-title":"Arthritis Res Ther"},{"key":"636_CR25","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002;46:2294\u2013300.","journal-title":"Arthritis Rheum"},{"key":"636_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73:492\u2013509.","journal-title":"Ann Rheum Dis"},{"key":"636_CR27","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/ard.2008.093690","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis. 2009;68:1100\u20134.","journal-title":"Ann Rheum Dis"},{"key":"636_CR28","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1086\/514093","volume":"176","author":"MH Nahm","year":"1997","unstructured":"Nahm MH, Olander JV, Magyarlaki M. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumonia. J Infect Dis. 1997;176:698\u2013703.","journal-title":"J Infect Dis"},{"key":"636_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1099\/jmm.0.067108-0","volume":"63","author":"EG Huijskens","year":"2014","unstructured":"Huijskens EG, Koopmans M, Palmen FM, van Erkel AJ, Mulder PG, Rossen JW. The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia. J Med Microbiol. 2014;63:441\u201352.","journal-title":"J Med Microbiol"},{"key":"636_CR30","doi-asserted-by":"crossref","unstructured":"Robinson K, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, et al. Active Bacterial Core Surveillance (ABCs)\/Emerging Infections Program Network. Epidemiology of Streptococcus pneumoniae infections in the U.S., 1995\u20131998: opportunities for prevention in the conjugate vaccine era. JAMA. 2001; 285:1729\u201335.","DOI":"10.1001\/jama.285.13.1729"},{"key":"636_CR31","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.vaccine.2014.02.096","volume":"32","author":"JD Grabenstein","year":"2014","unstructured":"Grabenstein JD, Musey LK. Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults. Vaccine. 2014;32:2399\u2013405.","journal-title":"Vaccine"},{"key":"636_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/rheumatology\/keq297","volume":"50","author":"SP Desai","year":"2011","unstructured":"Desai SP, Turchin A, Szent-Gyorgyi LE, Weinblatt M, Coblyn J, Solomon DH, et al. Routinely measuring and reporting pneumococcal vaccination among immunosuppressed rheumatology outpatients: the first step in improving quality. Rheumatology (Oxford). 2011;50:366\u201372.","journal-title":"Rheumatology (Oxford)"},{"key":"636_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/art.37716","volume":"65","author":"SP Desai","year":"2013","unstructured":"Desai SP, Lu B, Szent-Gyorgyi LE, Bogdanova AA, Turchin A, Weinblatt M, et al. Increasing pneumococcal vaccination for immunosuppressed patients: a cluster quality improvement trial. Arthritis Rheum. 2013;65:39\u201347.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0636-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-015-0636-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0636-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0636-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:36:45Z","timestamp":1728923805000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-015-0636-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0636-z","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]},"assertion":[{"value":"3 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"124"}}